Please login to the form below

Not currently logged in
Email:
Password:

Exjade

This page shows the latest Exjade news and features for those working in and with pharma, biotech and healthcare.

Novartis kicks back against US corruption charges

Novartis kicks back against US corruption charges

Last November, the company settled civil claims related to allegations of kickbacks involving specialty pharmacy prescribing of Myfortic and thalassaemia treatment Exjade (deferasirox), without admitting any liability.

Latest news

  • Biogen Idec taps Sangamo for blood disorder drugs Biogen Idec taps Sangamo for blood disorder drugs

    Meanwhile, supportive therapies are also available, notably Novartis' Exjade (deferasirox) which was approved in the EU last year to manage iron overload in thalassaemia.

  • Novartis' Exjade gets EU approval for thalassaemia Novartis' Exjade gets EU approval for thalassaemia

    Novartis' Exjade gets EU approval for thalassaemia. First oral treatment for condition characterised by red blood cell problems and anaemia. ... Approval in thalassaemia adds to the peak sales potential for Exjade and puts the medicine on track to meet

  • CHMP backs Novartis' Bexsero, Exjade CHMP backs Novartis' Bexsero, Exjade

    CHMP backs Novartis' Bexsero, Exjade. European recommendations for meningitis vaccine and thalassaemia treatment. ... Exjade is already approved in more than 100 countries to treat iron overload due to frequent blood transfusions, bringing in $633m in

  • Novartis' net income up 15 per cent for Q2

    Successful launches included Exjade (deferasirox), which made $192m after receiving regulatory approvals in the US and Europe for the treatment of chronic iron overload, and Certican/Zortress (everolimus) which made $26m

  • New accounts: January

    LiDCO. Intensive care medicine. Reynolds-MacKenzie. Novartis. Exjade. Sickle cell disease. Avenue.

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics